Toggle Sidebar
Home
AI Agent
Annotations
Files
Pricing and plans
Help
Blog
About
Contact us
API
MCP
Terms of service
Privacy policy
Get the full experience
We save the real magic for signed-in users.
Sign In
Home
Stock Screener
Document Search
Charting
Watchlists
Recent Filings
Moderna, Inc.
(MRNA US)
Follow
Doc Search
Profile
Entity Structure
SEC Filings
Financials
Charting
Short Interest
Employees
Toggle Sidebar
Home
AI Agent
Annotations
Files
Pricing and plans
Help
Blog
About
Contact us
API
MCP
Terms of service
Privacy policy
Get the full experience
We save the real magic for signed-in users.
Sign In
Home
Stock Screener
Document Search
Charting
Watchlists
Recent Filings
Moderna, Inc.
(MRNA US)
Follow
Doc Search
Profile
Entity Structure
SEC Filings
Financials
Charting
Short Interest
Employees
MRNA US
Ask AI
MRNA US
Ask AI
Chronological SEC Filings
Chronological SEC Filings
Select Filings
Non-Ownership Filings
(223)
Expand
10-Q
Q3
ended 30 Sept 2026
6 Nov
8-K
Results of Operations and Financial Condition
6 Nov
8-K
Moderna Adds Chief Operating Officer Role as Company Expands into Oncology
30 Sep
8-K
Moderna Announces Proposed Private Placement of $2.0 Billion of Convertible Senior Notes
1 Sep
10-Q
Q2
ended 30 Jun 2026
31 Jul
8-K
Results of Operations and Financial Condition
31 Jul
8-K
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
8 Jul
8-K
Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
11 May
10-Q
Q1
ended 31 Mar 2026
1 May
8-K
Results of Operations and Financial Condition
1 May
DEFA14A
DEFINITIVE ADDITIONAL PROXY SOLICITING MATERIALS
16 Mar
DEF 14A
DEFINITIVE PROXY STATEMENT
16 Mar
ARS
ANNUAL REPORT TO SECURITY HOLDERS
16 Mar
8-K
Entry into a Material Definitive Agreement
4 Mar
S-8
Registration statement (employee benefit plan)
20 Feb
10-K
FY 2025
ended 31 Dec 2025
20 Feb
8-K
Results of Operations and Financial Condition
13 Feb
8-K
Regulation FD Disclosure
10 Feb
8-K
Results of Operations and Financial Condition
12 Jan
8-K
Regulation FD Disclosure
5 Jan
Ownership Filings
(1.3K)
Expand
Form 4
Andres Juan
9 Nov
SC 13G/A
Moderna, Inc.
5 Nov
Form 4
Hoge Stephen
16 Oct
Form 144
Hoge Stephen
15 Oct
Form 144
Hoge Stephen
14 Oct
Form 4
Mock James M
7 Oct
Form 3
Andres Juan
5 Oct
Form 4
Hoge Stephen
16 Sep
Form 144
Hoge Stephen
15 Sep
Form 4
Mock James M
14 Sep
Form 144
Hoge Stephen
14 Sep
Form 144
Mock James M
10 Sep
Form 4
Mock James M
8 Sep
Form 4
Klinger Shannon Thyme
8 Sep
Form 4
Klinger Shannon Thyme
3 Sep
Form 4
Mock James M
3 Sep
Form 4
Hoge Stephen
3 Sep
Form 144
Klinger Shannon Thyme
1 Sep
Form 4
Hoge Stephen
31 Aug
Form 4
Klinger Shannon Thyme
31 Aug
Select Filings
Non-Ownership Filings
(223)
Expand
10-Q
Q3
ended 30 Sept 2026
6 Nov
8-K
Results of Operations and Financial Condition
6 Nov
8-K
Moderna Adds Chief Operating Officer Role as Company Expands into Oncology
30 Sep
8-K
Moderna Announces Proposed Private Placement of $2.0 Billion of Convertible Senior Notes
1 Sep
10-Q
Q2
ended 30 Jun 2026
31 Jul
8-K
Results of Operations and Financial Condition
31 Jul
8-K
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
8 Jul
8-K
Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
11 May
10-Q
Q1
ended 31 Mar 2026
1 May
8-K
Results of Operations and Financial Condition
1 May
DEFA14A
DEFINITIVE ADDITIONAL PROXY SOLICITING MATERIALS
16 Mar
DEF 14A
DEFINITIVE PROXY STATEMENT
16 Mar
ARS
ANNUAL REPORT TO SECURITY HOLDERS
16 Mar
8-K
Entry into a Material Definitive Agreement
4 Mar
S-8
Registration statement (employee benefit plan)
20 Feb
10-K
FY 2025
ended 31 Dec 2025
20 Feb
8-K
Results of Operations and Financial Condition
13 Feb
8-K
Regulation FD Disclosure
10 Feb
8-K
Results of Operations and Financial Condition
12 Jan
8-K
Regulation FD Disclosure
5 Jan
Ownership Filings
(1.3K)
Expand
Form 4
Andres Juan
9 Nov
SC 13G/A
Moderna, Inc.
5 Nov
Form 4
Hoge Stephen
16 Oct
Form 144
Hoge Stephen
15 Oct
Form 144
Hoge Stephen
14 Oct
Form 4
Mock James M
7 Oct
Form 3
Andres Juan
5 Oct
Form 4
Hoge Stephen
16 Sep
Form 144
Hoge Stephen
15 Sep
Form 4
Mock James M
14 Sep
Form 144
Hoge Stephen
14 Sep
Form 144
Mock James M
10 Sep
Form 4
Mock James M
8 Sep
Form 4
Klinger Shannon Thyme
8 Sep
Form 4
Klinger Shannon Thyme
3 Sep
Form 4
Mock James M
3 Sep
Form 4
Hoge Stephen
3 Sep
Form 144
Klinger Shannon Thyme
1 Sep
Form 4
Hoge Stephen
31 Aug
Form 4
Klinger Shannon Thyme
31 Aug
Ask in Filing
Ask in Filing
